Buprenorphine (Brixadi and Sublocade) for Opioid Use Disorder
Customize your policy alerts
Sign up for Colorado Rocky Mountain Health Plans Policy 2026D0057T alerts
Get alerted when Policy 2026D0057T changes without checking for updates manually.
Monitor payer policy activity
Coverage and prior authorization for Brixadi and Sublocade subcutaneous extended-release buprenorphine injections for moderate to severe opioid use disorder; pain management use is not medically necessary.
The policy was transferred to a shared template applying to both UnitedHealthcare Commercial and Individual Exchange benefit plans.
An Application section was added identifying UnitedHealthcare Commercial and Individual Exchange benefit plans.
The References section was updated with current information and previous policy versions were archived.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.